Effects of Taking Phenazopyridine (Pyridium)
Phenazopyridine (Pyridium) primarily acts as a urinary tract analgesic that relieves pain, burning, urgency, and frequency by exerting a topical analgesic effect on the urinary tract mucosa. 1
Primary Therapeutic Effects
- Local analgesic effect on urinary tract mucosa
Common Side Effects
Urine discoloration
Skin/sclera discoloration
- Yellowish tinge of skin or sclera may indicate drug accumulation due to impaired renal excretion 1
Serious Adverse Effects
Renal complications
Hematologic effects
Pharmacokinetics
- Rapidly excreted by the kidneys
- Up to 66% of an oral dose is excreted unchanged in the urine 1
- The complete pharmacokinetic profile has not been fully determined 1
Special Considerations
Renal Function
- Patients with impaired renal function are at higher risk for adverse effects due to drug accumulation 1, 5
- Regular monitoring of renal function may be necessary in patients with kidney disease
Laboratory Interactions
- May interfere with urinalysis based on spectrometry or color reactions due to its properties as an azo dye 1
Pregnancy Considerations
- Classified as Pregnancy Category B
- Animal studies show no evidence of fetal harm, but adequate human studies are lacking
- Should only be used during pregnancy if clearly needed 1
Dosing Guidelines
For urinary tract pain relief:
- Standard dose: 200 mg three times daily 3
- Short-term use is recommended (2 days or less)
- For cystoscopy-related discomfort: 200 mg 20 minutes before procedure, then 200 mg every 8 hours (total of three doses) 2
Important Precautions
Monitor for signs of drug accumulation (yellow skin/sclera) which may indicate the need to discontinue therapy 1
Be aware of potential carcinogenic effects with long-term use (has induced neoplasia in animal studies) 1
Use with extreme caution in patients with renal impairment or elderly patients with declining renal function 1, 5
Inform patients about the normal urine discoloration to prevent unnecessary concern 1
Discontinue if signs of methemoglobinemia, hemolytic anemia, or other serious adverse effects develop 5